Voices For Life

Voices for Life is an e-publication dedicated to informing and educating the public on pro-life and pro-family issues. We cover issues from conception until natural death, as well as all family life issues.

Saturday, July 8, 2017

Charlie Gard: May Leaves Door Open for Treatment Abroad as US Hospital Offers to Treat Him for Free


By Fox News World

British Prime Minister Theresa May left the door open for the terminally ill infant Charlie Gard to receive treatment outside the United Kingdom, as the Vatican and hospitals in the U.S. offered to care for the baby.

May told the House of Commons Wednesday that she understands that the 11-month-old’s parents are in an “unimaginable situation” and are trying to do what’s right for their child, but that in cases like this doctors are forced to make “heartbreaking decisions.”

She said earlier in the week, “I am confident that Great Ormond Street Hospital have and always will consider any offers or new information that has come forward with consideration of the well-being of a desperate ill child.”

Charlie Gard is suffering from a rare genetic condition that has damaged his brain and left him unable to breathe without assistance. His parents have said they want to take him to the U.S. for an experimental medical treatment they believe may prolong his life.

The Guardian reported that an unnamed hospital in the U.S. has offered to treat Charlie free of charge.

However, a succession of judges backed specialists at Great Ormond Street Hospital in London who've said the therapy won’t help Charlie and may cause him to suffer.

President Donald Trump and Pope Francis brought international attention to the family’s legal battle this week by commenting on a case that pits the rights of parents to decide what’s best for their children against the responsibility of authorities to make sure children receive the most appropriate care.
“If we can help little #CharlieGard, as per our friends in the U.K. and the Pope, we would be delighted to do so,” Trump tweeted earlier this week.

No comments:

Post a Comment